menu
    • menu

    Company profile for EOM Pharmaceuticals

    NEW Drugs in Dev: 1
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    EOM Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing novel drugs with the potential to transform therapeutic paradigms and improve the quality of life in patients suffering from debilitating and sometimes deadly diseases. EOM’s pipeline is built on novel compounds with the potential to transform therapeutic paradigms and potentially improve the quality of life in patients suffering from debili...
    EOM Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing novel drugs with the potential to transform therapeutic paradigms and improve the quality of life in patients suffering from debilitating and sometimes deadly diseases. EOM’s pipeline is built on novel compounds with the potential to transform therapeutic paradigms and potentially improve the quality of life in patients suffering from debilitating and sometimes deadly diseases. EOM pharmaceuticals has two pipeline assets in their portfolio, EOM613 and EOM147.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    EOM PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    36 Summit Ave., Suite 100 Montvale, NJ 07645
    Telephone
    Telephone
    +1 2013510605
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.eompharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/eompharma/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/eompharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    EOM Pharma Gets IND Clearance for Cachectic Cancer Trial
    EOM Pharma Gets IND Clearance for Cachectic Cancer Trial

    27 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/27/3301943/0/en/eom-pharmaceutical-holdings-reports-fda-clearance-of-an-ind-for-a-clinical-trial-in-cachectic-cancer-patients.html

    GLOBENEWSWIRE
    27 May 2026
    Share Share
    EOM Pharma Updates EOM613 EOM147 Preclinical Results
    EOM Pharma Updates EOM613 EOM147 Preclinical Results

    07 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/07/3214524/0/en/EOM-Pharmaceutical-Holdings-Reports-Promising-Preclinical-Results-and-Provides-an-Update-on-EOM613-and-EOM147.html

    GLOBENEWSWIRE
    07 Jan 2026
    Share Share
    EOM Pharma Announces Topline Results of its COVID-19 Clinical Trial of EOM613
    EOM Pharma Announces Topline Results of its COVID-19 Clinical Trial of EOM613

    06 Sep 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eom-pharmaceutical-holdings-announces-topline-results-of-its-covid-19-clinical-trial-of-eom613-in-brazil-301918019.html

    PR NEWSWIRE
    06 Sep 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search